Helsinki, Finland

Reijo Bäckström


 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2005-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Reijo Bäckström - Innovator in Pharmaceutical Development

Introduction

Reijo Bäckström is a prominent inventor based in Helsinki, Finland, known for his contributions to pharmaceutical innovations. With a total of three patents to his name, Bäckström has made significant strides in developing compounds that exhibit therapeutic benefits, particularly in treating serious medical conditions.

Latest Patents

Bäckström's latest patents include two key pharmaceutical inventions. The first patent pertains to pharmaceutical compounds characterized by their COMT enzyme inhibiting activity, which positions them as useful inhibitors in various medical applications. The second major patent involves pharmaceutical solutions of levosimendan, particularly formulated for intravenous administration. These solutions boast enhanced stability, making them ideal for infusion or injection purposes and particularly beneficial in treating congestive heart failure.

Career Highlights

Currently, Reijo Bäckström is employed at Orion Corporation, a significant player in the pharmaceutical sector. His dedication to research and development has propelled him to the forefront of pharmaceutical innovations, contributing to both healthcare and patient quality of life through his inventions.

Collaborations

Throughout his career, Bäckström has teamed up with several esteemed colleagues, including Jarmo J Pystynen and Timo Lotta. Their collaborations have fostered an environment of innovation and creativity, leading to successful advancements in the pharmaceutical industry.

Conclusion

Reijo Bäckström continues to make impactful contributions in the field of pharmaceuticals. With his inventive spirit and dedication, he remains a notable figure in the advancement of medical science, paving the way for new treatment options and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…